| Pharmacokinetic aspects of retinal drug delivery EM Del Amo, AK Rimpelä, E Heikkinen, OK Kari, E Ramsay, T Lajunen, ... Progress in retinal and eye research 57, 134-185, 2017 | 543 | 2017 |
| Enzyme controlled glucose auto-delivery for high cell density cultivations in microplates and shake flasks J Panula-Perälä, J Šiurkus, A Vasala, R Wilmanowski, MG Casteleijn, ... Microbial cell factories 7, 1-12, 2008 | 206 | 2008 |
| Application of aptamers in diagnostics, drug-delivery and imaging C Chandola, S Kalme, MG Casteleijn, A Urtti, M Neerathilingam Journal of Biosciences, 1-27, 2016 | 76 | 2016 |
| Expression without boundaries: cell-free protein synthesis in pharmaceutical research MG Casteleijn, A Urtti, S Sarkhel International journal of pharmaceutics 440 (1), 39-47, 2013 | 71 | 2013 |
| Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material DMAM Luykx, MG Casteleijn, W Jiskoot, J Westdijk, PMJM Jongen European journal of pharmaceutical sciences 23 (1), 65-75, 2004 | 57 | 2004 |
| Functional Role of the Conserved Active Site Proline of Triosephosphate Isomerase, MG Casteleijn, M Alahuhta, K Groebel, I El-Sayed, K Augustyns, ... Biochemistry 45 (51), 15483-15494, 2006 | 53 | 2006 |
| Spin coated chitin films for biosensors and its analysis are dependent on chitin-surface interactions MG Casteleijn, D Richardson, P Parkkila, N Granqvist, A Urtti, T Viitala Colloids and Surfaces A: Physicochemical and Engineering Aspects 539, 261-272, 2018 | 25 | 2018 |
| Assessment of recombinant protein production in E. coli with Time-Gated Surface Enhanced Raman Spectroscopy (TG-SERS) M Kögler, J Itkonen, T Viitala, MG Casteleijn Scientific Reports 10 (2472), 2020 | 24 | 2020 |
| Structure-based protein engineering efforts with a monomeric TIM variant: the importance of a single point mutation for generating an active site with suitable binding properties M Alahuhta, M Salin, MG Casteleijn, C Kemmer, I El-Sayed, K Augustyns, ... Protein Engineering, Design & Selection 21 (4), 257-266, 2008 | 23 | 2008 |
| CD44 aptamer mediated cargo delivery to lysosomes of retinal pigment epithelial cells to prevent age-related macular degeneration C Chandola, MG Casteleijn, UM Chandola, LN Gopalan, A Urtti, ... Biochemistry and Biophysics Reports 18, 100642, 2019 | 17 | 2019 |
| High-temperature cultivation and 5′ mRNA optimization are key factors for the efficient overexpression of thermostable Deinococcus geothermalis purine nucleoside phosphorylase … K Szeker, O Niemitalo, MG Casteleijn, AH Juffer, P Neubauer Journal of biotechnology 156 (4), 268-274, 2011 | 17 | 2011 |
| Interaction of lecithin: cholesterol acyltransferase with lipid surfaces and apolipoprotein AI-derived peptides MG Casteleijn, P Parkkila, T Viitala, A Koivuniemi Journal of lipid research 59 (4), 670-683, 2018 | 16 | 2018 |
| Crystallographic binding studies with an engineered monomeric variant of triosephosphate isomerase M Salin, EG Kapetaniou, M Vaismaa, M Lajunen, MG Casteleijn, ... Acta Crystallographica Section D: Biological Crystallography 66 (8), 934-944, 2010 | 16 | 2010 |
| Structural studies show that the A178L mutation in the C-terminal hinge of the catalytic loop-6 of triosephosphate isomerase (TIM) induces a closed-like conformation in dimeric … M Alahuhta, MG Casteleijn, P Neubauer, RK Wierenga Acta Crystallographica Section D: Biological Crystallography 64 (2), 178-188, 2008 | 14 | 2008 |
| Accelerated pharmaceutical protein development with integrated cell free expression, purification, and bioconjugation D Richardson, J Itkonen, J Nievas, A Urtti, MG Casteleijn SCiEnTiFiC RepoRTS 8 (1), 11967, 2018 | 9 | 2018 |
| Characterization, stability, and in vivo efficacy studies of recombinant human CNTF and its permeation into the neural retina in ex vivo organotypic retinal explant culture models J Itkonen, A Annala, S Tavakoli, B Arango-Gonzalez, M Ueffing, ... Pharmaceutics 12 (7), 611, 2020 | 8 | 2020 |
| Engineering cells and proteins – creating pharmaceuticals MG Casteleijn, D Richardson European Pharmaceutical Review 19 (4), 12-19, 2014 | 6 | 2014 |
| Towards new enzymes: protein engineering versus Bioinformatic studies MG casteleijn University of Oulu, 2009 | 2 | 2009 |
| Controlled high-cell density cultivation in shake flasks J Panula-Perälä, M Casteleijn, A Vasala, P Neubauer Journal of Biotechnology 2 (131), S182, 2007 | 2 | 2007 |
| Analysis of Biologics Molecular Descriptors towards Predictive Modelling for Protein Drug Development Using Time-Gated Raman Spectroscopy J Itkonen, L Ghemtio, D Pellegrino, PJ Jokela, H Xhaard, MG Casteleijn Pharmaceutics 14 (8), 1639, 2022 | 1 | 2022 |
Peter NeubauerTU Berlin, Professor of Bioprocess EngineeringVerified email at tu-berlin.de
